Improving lung health Protects lung tissues from oxidative damage
An unlicensed medicinal product should not be supplied where an equivalent licensed medicinal product can meet the special needs of the patient
one involves inhibiting dipeptidyl peptidase-4 (DPP-4), the enzyme that deactivates GIP and GLP-1
With extensive Phase 3 data across diabetes (SUSTAIN trials) and obesity (STEP trials), Semaglutide serves as a benchmark comparator for researchers studying newer metabolic peptides including Tirzepatide and Retatrutide
Using the microbial esterase of the gut microbiota, sugars, organic acids, and lipids can be converted into aglycans
Large network meta-analysis of 100 trials and 25,952 patients that demonstrated olanzapine and clozapine have the worst metabolic profiles while aripiprazole, brexpiprazole, cariprazine, lurasidone, and ziprasidone have the most benign profiles